AHA opposes any further delay of 340B drug ceiling price rule

AHA News Now

The AHA today urged the Health Resources and Services Administration to implement its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers without delay. “Delaying the implementation of the ceiling price and CMPs an additional nine months – from Oct. 1, 2017 to July 1,... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, drug prices

Senate holds hearing on health care cost, coverage issues

AHA News Now

The Senate Finance Committee today held a hearing on issues impacting health care costs and coverage. Witnesses included former Centers for Medicare & Medicaid Services Acting Administrator Andy Slavitt and representatives from the Foundation for Research on Equal Opportunity, Heritage Foundation, and... read more

Topic: Advocacy and Public Policy
Tags: Coverage, drug prices

AHA urges CMS to withdraw proposed cut to 340B program

AHA News Now

The Centers for Medicare & Medicaid Services should withdraw its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program, AHA today told the agency in comments on its outpatient prospective payment system proposed rule for calendar year 2018. “CMS lacks... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare, rural, Critical Access Hospitals, regulation, drug prices

President signs FDA Reauthorization Act

AHA News Now

President Trump Friday signed into law the FDA Reauthorization Act (H.R. 2430). The bill reauthorizes and amends four FDA user fee programs under which companies that develop drugs and medical devices partially pay for premarket review of their products. The bill also includes provisions intended to... read more

Topic: Advocacy and Public Policy
Tag: drug prices

CMS projects Part D monthly premium to decline slightly in 2018

AHA News Now

The average monthly premium for a basic Medicare Part D prescription drug plan in 2018 is estimated to be $33.50 per month – or approximately $1.20 less than the average premium in 2017 – the Centers for Medicare & Medicaid Services announced last week. The projection is based on bids submitted by drug... read more

Topic: Access and Coverage
Tag: drug prices

Senate passes FDA Reauthorization Act

AHA News Now

The Senate yesterday voted 94-1 to approve the FDA Reauthorization Act (H.R. 2430), sending the legislation to the president for his signature. The bill reauthorizes and amends four FDA user fee programs under which companies that develop drugs and medical devices partially pay for premarket review of... read more

Topic: Advocacy and Public Policy
Tags: regulation, opioids, drug prices

Democratic leaders unveil economic agenda

AHA News Now

Senate Democratic Leader Charles Schumer and House Democratic Leader Nancy Pelosi today unveiled an economic plan focused on improving wages, lowering costs and boosting job opportunities. To lower the cost of prescription drugs, the plan calls for creating a new agency to investigate and take action... read more

Topic: Advocacy and Public Policy
Tags: Medicare, drug prices

CMS releases 2018 OPPS/ASC proposed rule

AHA News Now

The Centers for Medicare & Medicaid Services today proposed to update hospital outpatient prospective payment system rates by 1.75% in calendar year 2018 compared to CY 2017. The rule also would drastically cut Medicare payment for drugs that are acquired under the 340B Drug Pricing Program. Specifically,... read more

Topic: Advocacy and Public Policy
Tags: 340B, quality, physicians, site neutral payment, Medicare, rural, Critical Access Hospitals, regulation, drug prices

MedPAC issues June report to Congress

AHA News Now

The Medicare Payment Advisory Commission yesterday released its June report to Congress, which includes the panel’s recent recommendations for reforming Medicare payment for Part B drugs and accelerating the roll out of a post-acute care prospective payment system. The report also discusses possible... read more

Topic: Advocacy and Public Policy
Tags: physicians, Medicare, rural, emergency care, drug prices

AHA urges Congress to address rising cost of drugs

AHA News Now

The AHA today urged Congress and the administration to take immediate action to rein in the rising cost of drugs. In a statement submitted to the Senate Committee on Health, Education, Labor and Pensions for a hearing on the issue, AHA offered specific recommendations to increase competition, innovation... read more

Topic: Advocacy and Public Policy
Tag: drug prices

Keyword Search

Types

Date